Earlier quoted context omitted.
No. What's really happening is that they did provide a lot of probability estimates for some pretty serious stuff - back in the day before the FDA told them to stop doing it. I know because I carry a higher risk allele for a non-trivial disease (along with lower risk alleles for some other non-trivial diseases), and the test placed me in those corresponding statistical risk buckets which are different from the genera…
I agree with your assessment of the situation, but I'd still be very surprised if e.g. a Huntington's test shows up in 23andme, and I think that's because the FDA doesn't trust consumers to react appropriately to receiving serious and actionable information from 23andme.
So, that is an interesting and valid point. I've thought about it myself. Seems like these tests are something new, and it may take a while before the new thing is absorbed into the culture and it's treated the way it should. Yes, there is still the risk of misunderstanding the information you're getting.
There are also a few simple solutions - e.g. any doctor should be able to help you correctly integrate this information.